Drug profile · INN
filgrastim-sndz
ZARXIO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
filgrastim-sndz (ZARXIO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN filgrastim-sndz
Brand ZARXIO
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is filgrastim-sndz?
filgrastim-sndz (ZARXIO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for filgrastim-sndz?
ZARXIO is a marketed brand name for filgrastim-sndz. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of filgrastim-sndz?
filgrastim-sndz has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.